ArticleCell cycle (Georgetown, Tex.)2012

An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells.

Ingeborg M M van Leeuwen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.